<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Since June 1985, 121 patients with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> aged 24-61 years (median 43) have received myeloablative therapy (<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>: 60 mg/kg x 2, + total body irradiation: 200 cGy x 6) with autologous bone marrow transplantation (CY+TBI+ABMT) as consolidation of 2nd or subsequent remission </plain></SENT>
<SENT sid="1" pm="."><plain>The marrow mononuclear cell fraction was treated in vitro with anti-CD20 alone and baby rabbit complement at St </plain></SENT>
<SENT sid="2" pm="."><plain>Bartholomew's Hospital (SBH) and with the addition of anti-B5 and anti-CD10 at the Dana Farber <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute (DFCI) prior to reinfusion </plain></SENT>
<SENT sid="3" pm="."><plain>There were 4 treatment related <z:hpo ids='HP_0011420'>deaths</z:hpo>, (nonengraftment 1, haemorrhage 1, <z:e sem="disease" ids="C0553576" disease_type="Disease or Syndrome" abbrv="">systemic fungal infection</z:e> 1, <z:e sem="disease" ids="C0948441" disease_type="Disease or Syndrome" abbrv="VOD">veno-occlusive disease</z:e> 1) </plain></SENT>
<SENT sid="4" pm="."><plain>The median time for neutrophil recovery (&gt; 0.5 x 10(9)/1) was 26 days (range 10 to 59 days), and for platelets (&gt; 20 x 10(9)/1), 30 days (range 12 to 73 days) </plain></SENT>
<SENT sid="5" pm="."><plain>One patient did not engraft and 7 have had delayed recovery of red cells and platelets (&gt; 3 months) </plain></SENT>
<SENT sid="6" pm="."><plain>Two other patients have subsequently developed <z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and 5, evidence of myelodyplasia </plain></SENT>
<SENT sid="7" pm="."><plain>Seventy-one patients continue in unmaintained remission between 3 months and 7 years, with a median follow up of 2.5 years </plain></SENT>
<SENT sid="8" pm="."><plain>Forty-three have developed recurrent <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; 98 remain alive </plain></SENT>
<SENT sid="9" pm="."><plain>Freedom from progression was the same, irrespective of whether patients received CY + TBI + ABMT whilst in a complete or partial remission and did not depend on the specific remission in which treatment was given (2nd: 90 patients vs. &gt; 2nd: 31 patients).(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>